Medifast, Inc. (MED)
12.14
-0.04
(-0.33%)
USD |
NYSE |
Jun 10, 16:00
12.16
+0.02
(+0.12%)
Pre-Market: 20:00
Medifast Accounts Payable (Quarterly) : 38.26M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 38.26M |
| December 31, 2025 | 38.36M |
| September 30, 2025 | 41.24M |
| June 30, 2025 | 40.26M |
| March 31, 2025 | 51.82M |
| December 31, 2024 | 56.49M |
| September 30, 2024 | 66.27M |
| June 30, 2024 | 69.15M |
| March 31, 2024 | 71.23M |
| December 31, 2023 | 39.19M |
| September 30, 2023 | 103.22M |
| June 30, 2023 | 105.19M |
| March 31, 2023 | 113.30M |
| December 31, 2022 | 134.69M |
| September 30, 2022 | 148.13M |
| June 30, 2022 | 154.78M |
| March 31, 2022 | 174.37M |
| December 31, 2021 | 163.31M |
| September 30, 2021 | 155.51M |
| June 30, 2021 | 149.02M |
| March 31, 2021 | 141.25M |
| December 31, 2020 | 107.68M |
| September 30, 2020 | 108.68M |
| June 30, 2020 | 103.34M |
| March 31, 2020 | 78.59M |
| Date | Value |
|---|---|
| December 31, 2019 | 76.22M |
| September 30, 2019 | 75.02M |
| June 30, 2019 | 73.57M |
| March 31, 2019 | 74.45M |
| December 31, 2018 | 60.32M |
| September 30, 2018 | 62.81M |
| June 30, 2018 | 53.44M |
| March 31, 2018 | 38.19M |
| December 31, 2017 | 16.15M |
| September 30, 2017 | 26.25M |
| June 30, 2017 | 25.14M |
| March 31, 2017 | 23.15M |
| December 31, 2016 | 9.58M |
| September 30, 2016 | 24.42M |
| June 30, 2016 | 22.36M |
| March 31, 2016 | 23.82M |
| December 31, 2015 | 11.26M |
| September 30, 2015 | 20.18M |
| June 30, 2015 | 21.26M |
| March 31, 2015 | 25.47M |
| December 31, 2014 | 21.85M |
| September 30, 2014 | 27.09M |
| June 30, 2014 | 25.21M |
| March 31, 2014 | 26.16M |
| December 31, 2013 | 26.78M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Integrated BioPharma, Inc. | 2.965M |
| Skinvisible, Inc. | 1.355M |
| Nevis Brands, Inc. | 0.1906M |
| Functional Brands, Inc. | 0.6222M |
| USANA Health Sciences, Inc. | 16.23M |